Macular Degeneration Foundation

AAO 2019: Joe Fontenot MD CLVT

Joe Fontenot, MD, CLVT Medical Director Community Services for Vision Rehabilitation http://www.csvrlowvision.org MOBILE, AL 251-476-4744 DAPHNE, AL 251-928-2888 Presentation: New Technologies, approaches and techniques for low vision community

AAO 2019: Rahul Khurana MD

Rahul Khurana, MD Northern California Vitreous Associates http://www.ncrva.com Presentation: New treatment possibilities for Neovascular Macular Degeneration

AAO 2019: Charles Wykoff MD PhD

Charles Wykoff MD PhD Retinal Consultants of Houston http://www.houstonretina.com (713) 524-3434 Presentation: A Phase I/Ib Open Label, Multi-center Exploratory Study to Investigate the Bioactivity, Ocular and Systemic Safety, Tolerability, and Pharmacokinetics Following Single and Multiple Intravitreal Administrations of KSI-301 in Subjects With Wet Age-Related Macular Degeneration, Diabetic Macular Edema and …

AAO 2019: Franco M Recchia MD

Franco M Recchia MD Tennessee Retina (615) 983-6000 http://www.tnretina.com Presentation: Clinical Trial Outcomes and Real-World Patients

AAO 2019: Ronald Gentile MD

Ronald Gentile, MD, FACS, FASRSGentile RetinaRetina Surgeon at The New York Eye and Ear Infirmary of Mount Sinai (NYEE) http://www.gentileretina.com 1-212-979-4120 http://www.NYEE.edu Presentation: S.A.T.I.S.F.Y your patient

AAO 2019: Tom Perski

Tom Perski, VP Iris Vision Global Sales: (855) 449-4536 Support: (855) 207-6665 Irisvision.com Presentation: New features and accessibility available in wearable low vision devices designed for people with limited field of vision

AAO 2019: Shailesh Gupta MD

Shailesh Gupta MD Coral Springs/Boca Raton (561) 322-3588 http://specialtyretina.com Presentation: Comparative Evaluation Of Fonts In Electronic Tablet–Assisted Improvement Of Reading Ability As Well As Quality Of Life In Patients With Poor Vision Secondary To Macular Degeneration

AAO 2019: David S Boyer MD

David S Boyer MD Retina-Vitrieous Associates Medical Group Adjunct Clinical Professor at USC http://www.laretina.com Los Angeles, CA Phone: (213) 483-8810 Presentation: Early treatment for dry AMD Prophylaxis Intravitreal Aflibercept Injection Against Conversion to nAMD in High-Risk Eyes (PRO-CON): 24-Month Results

AAO 2019: Richard Rosen MD

Richard Rosen, MD at AAO 2019Icahn School of Medicine at Mount Sinai New York Eye and Ear Infirmary of Mt Sinaihttp://www.nyee.edu212-979-4288 Presentation: Metabolic Imaging Using Flavoprotein Autofluorescence

AAO 2019: Jakob Siedlecki MD

Jakob Siedlecki, MD Ludwig-Maximilians-University of Munich Presentation: Growth Rate of Primary Geographic Atrophy Complicated by Active CNV ( choroidal neovascularization ) in AMD

AAO 2019: Mitul Mehta MD

Mitul Mehta, MD UC Irvine EYEDAPTIC Presentation: Performance of an Augmented Reality Device on Functional Activities for people with AMD

AAO 2019: Philip Hessburg MD

Presentation: Nano Electronic Visual Prosthetic Devices Eye and the ChipDetroit Institute of Ophthalmology Henry Ford Health System 313-936-1968 Office rhorne1@hfhs.org Website: https://www.henryford.com/hcp

AAO 2019: Philip Hessburg MD

Philip Hessburg, MD Detroit institute of Ophthalmology Henry Ford Health System Presentation: What “blindness” means for AMD patients

AAO 2019: David A Eichenbaum MD

Presentation: Additional Anatomic Endpoints Support Sustained Outcomes With Faricimab Every 16 Weeks in the STAIRWAY Phase 2 Trial for neovascular AMD David A Eichenbaum MDRetina Vitreous Associates of FloridaSAINT PETERSBURG (727) 323-0077CLEARWATER (727) 445-9110TAMPA (813) 879-5795 https://retinavitreous.com

EYESIGHT 2019: Sarah Zhang MD

Sarah Zhang MD University at Buffalo Jacobs School of Medicine and Biomedical Sciences Presented research: Loss of XBP1 accelerates age-related decline in retinal function and neurodegeneration

EYESIGHT 2019: Sayon Roy PhD

Sayon Roy PhD FARVO Conference Chairman Professor of Medicine and Ophthalmology Boston University School of Medicine About USG EYE 2019 Meeting Presented research: Vascular Basement Membrane Thickening in Diabetic Retinopathy

EYESIGHT 2019: Renu Kowluru PhD

Renu Kowluru PhDWayne State University, Detroit, MI Presented research:Mitochondria and a Web of Epigenetics

EYESIGHT 2019: Sandra Hammer PhD

Sandra Hammer, PhD Research Associate, Busik Lab Michigan State University Topic: The Role of the SIRT1/LXR Signaling Axis in Retinal Endothelial Cell Inflammation and Metabolism

EYESIGHT 2019: Takeshi Iwata PhD

Takeshi Iwata PhD Director of Molecular and Cellular Biology Division Vice President of International Society for Eye Research Head of Japan Eye Genetics Consortium President of Global Eye Genetics Consortium National Institute of Sensory Organs National Hospital Organization Tokyo Medical Center Topic: Elucidating Molecular Mechanisms and Developing Therapeutics for Retinal …

ARVO 2019: Anneke denHollander PhD

Anneke denHollander, PhDGenetics of Multifactorial Eye DiseasesRadboudUMCARVO 2019 Topic: Risk factors for Fellow Eye Progression in Patients with Age-Related Macular Degeneration

ARVO 2019: Madhu Cherukury PhD

Madhu Cherukury PhDAllgenesis Biotherapeutics Inc.http://www.allgenesis.comARVO 2019 Topic: AG-73305, a Novel Multi-specific Fc-fusion Protein under Development for the Treatment of Diabetic Macular Edema

ARVO 2019: Christopher Moen MD

Christopher Moen MD President Choroideremia Research Foundation http://www.curechm.org Topic: Connecting Researchers and Clinicians to Cope with Vision Loss

ARVO 2019: Gena Harper

Gena Harper Morgan Stanley Wealth Management Senior Vice President-Wealth Management Senior Investment Management Consultant ARVO 2019 Topic: Tips for Thriving with Low Vision & Blindness

ARVO 2019: Valeria Canto-Soler PhD

Valeria Canto-Soler PhD Doni Solich Family Chair in Ocular Stem Cell Research Dir. of CellSight – Ocular Stem Cell and Regeneration Program Associate Professor – Department of Ophthalmology University of Colorado School of Medicine Topic: Retinal transplant to treat Dry AMD http://www.ucdenver.edu